scholarly journals A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain

2021 ◽  
Vol 22 (2) ◽  
pp. 835
Author(s):  
Nakul Ravi Raval ◽  
Annette Johansen ◽  
Lene Lundgaard Donovan ◽  
Nídia Fernandez Ros ◽  
Brice Ozenne ◽  
...  

A single dose of psilocybin, a psychedelic and serotonin 2A receptor (5-HT2AR) agonist, may be associated with antidepressant effects. The mechanism behind its antidepressive action is unknown but could be linked to increased synaptogenesis and down-regulation of cerebral 5-HT2AR. Here, we investigate if a single psychedelic dose of psilocybin changes synaptic vesicle protein 2A (SV2A) and 5-HT2AR density in the pig brain. Twenty-four awake pigs received either 0.08 mg/kg psilocybin or saline intravenously. Twelve pigs (n = 6/intervention) were euthanized one day post-injection, while the remaining twelve pigs were euthanized seven days post-injection (n = 6/intervention). We performed autoradiography on hippocampus and prefrontal cortex (PFC) sections with [3H]UCB-J (SV2A), [3H]MDL100907 (5-HT2AR antagonist) and [3H]Cimbi-36 (5-HT2AR agonist). One day post psilocybin injection, we observed 4.42% higher hippocampal SV2A density and lowered hippocampal and PFC 5-HT2AR density (−15.21% to −50.19%). These differences were statistically significant in the hippocampus for all radioligands and in the PFC for [3H]Cimbi-36 only. Seven days post-intervention, there was still significantly higher SV2A density in the hippocampus (+9.24%) and the PFC (+6.10%), whereas there were no longer any differences in 5-HT2AR density. Our findings suggest that psilocybin causes increased persistent synaptogenesis and an acute decrease in 5-HT2AR density, which may play a role in psilocybin’s antidepressive effects.

Author(s):  
Nakul Ravi Raval ◽  
Annette Johansen ◽  
Lene Lundgaard Donovan ◽  
Nídia Fernandez Ros ◽  
Brice Ozenne ◽  
...  

A single dose of psilocybin, a psychedelic and serotonin 2A receptor (5-HT2AR) agonist, may be associated with antidepressant effects. The mechanism behind its antidepressive action is unknown but could be linked to increased synaptogenesis and down-regulation of cerebral 5-HT2AR. Here, we investigate if a single psychedelic dose of psilocybin changes synaptic vesicle protein 2A (SV2A) and 5-HT2AR density in the pig brain. Twenty-four awake pigs received either 0.08 mg/kg psilocybin or saline intravenously. Twelve pigs (n=6/intervention) were euthanized one day post-injection, while the remaining twelve pigs were euthanized seven days post-injection (n=6/intervention). We performed autoradiography on hippocampus and prefrontal cortex (PFC) sections with [3H]UCB-J (SV2A), [3H]MDL100907 (5-HT2AR antagonist) and [3H]Cimbi-36 (5-HT2AR agonist). One day post psilocybin injection, we observed 4.4% higher hippocampal SV2A density and lowered hippocampal and PFC 5-HT2AR density (-15.21% to -50.19%). These differences were statistically significant in the hippocampus for all radioligands and in PFC for [3H]Cimbi-36 only. Seven days post-intervention, there was still significantly higher SV2A density in hippocampus (+9.24%) and PFC (+6.1%) whereas there were no longer any differences in 5-HT2AR density. Our findings suggest that psilocybin’s antidepressive actions are linked to increased persistent synaptogenesis and possibly also to an acute decrease in 5-HT2AR density.


2020 ◽  
Vol 40 ◽  
pp. S453-S454
Author(s):  
N.R. Raval ◽  
A. Johansen ◽  
L.L. Donovan ◽  
N.F. Ros ◽  
B. Ozenne ◽  
...  

2020 ◽  
Vol 11 (9) ◽  
pp. 1238-1244
Author(s):  
Emil Marcher-Rørsted ◽  
Adam L. Halberstadt ◽  
Adam K. Klein ◽  
Muhammad Chatha ◽  
Simon Jademyr ◽  
...  

2016 ◽  
Vol 105 ◽  
pp. 142-153 ◽  
Author(s):  
Gaël Qesseveur ◽  
Anne Cécile Petit ◽  
Hai Thanh Nguyen ◽  
Lionel Dahan ◽  
Romain Colle ◽  
...  

2013 ◽  
Vol 91 (5) ◽  
pp. 634-641 ◽  
Author(s):  
Martin A. Santini ◽  
Cecilia Ratner ◽  
Susana Aznar ◽  
Anders B. Klein ◽  
Gitte M. Knudsen ◽  
...  

2017 ◽  
Vol 815 ◽  
pp. 138-146 ◽  
Author(s):  
Alba Iglesias ◽  
Marta Cimadevila ◽  
Rocío Ailim de la Fuente ◽  
María Martí-Solano ◽  
María Isabel Cadavid ◽  
...  

2013 ◽  
Vol 27 (10) ◽  
pp. 903-914 ◽  
Author(s):  
Bettina Hornboll ◽  
Julian Macoveanu ◽  
James Rowe ◽  
Rebecca Elliott ◽  
Olaf B Paulson ◽  
...  

2007 ◽  
Vol 65 (1) ◽  
pp. 11-14 ◽  
Author(s):  
Vivian Bertola ◽  
Quirino Cordeiro ◽  
Stevin Zung ◽  
Elisabete Cristina Miracca ◽  
Homero Vallada

Data from epidemiological studies have demonstrated that genetics is an important risk factor for schizophrenia. Disturbances of serotonergic brain pathways have been implicated in the pathophysiology of schizophrenia. Some studies have suggested that the efficacy of atypical antipsychotics on schizophrenia treatment may be related to the serotonin 2A receptor (5-HT2A), and that serotonergic drugs may induce psychotic symptoms. Thus, the aim of this study was to investigate the association between the C516T polymorphism and schizophrenia in a Brazilian population composed by 246 patients and 315 healthy matched controls in a case-control approach. No statistically differences were observed in allelic (chi2=1.77, 1d.f., p=0.18) or genotypic (chi2=1.69, 2d.f., p=0.42) distributions between cases and controls. The results suggest that the C516T polymorphism of the 5-HT2A receptor gene is not related to the susceptibility for schizophrenia in our Brazilian sample.


Sign in / Sign up

Export Citation Format

Share Document